Mirati Therapeutics Inc (NASDAQ: MRTX), a clinical-stage targeted oncology company, has named Jenny Gizzi as its new vice president, Human Resources, it was reported yesterday.
Gizzi will report directly to Charles M Baum, MD, PhD, president and chief executive officer. In her role, she will be responsible for all aspects of the company's human resources operations and strategy, including managing the planning, development, implementation and administration of Mirati's human resources programs. She will also be responsible for long range human resources planning to assist Mirati with continued growth.
Gizzi joins Mirati Therapeutics with more than 20 years of experience in human resources, most recently serving as the head of Strategy & Operations, Business Insights and Analytics at Bristol-Myers Squibb. Earlier in her career at Bristol-Myers Squibb, Gizzi served as head of Human Resources for the Bay Area and Cambridge, and head of Global Talent for European Markets, Australia and Canada where her responsibilities included heading global talent for eight markets and 13 countries and leading the international team specialising in creation of overall talent strategy. Prior to her time at Bristol-Myers Squibb, she was head of Global Talent Acquisition for Illumina Inc where she was ultimately responsible for their talent function globally.
Futura Medical appoints Market Performance Group as new US distribution partner for Eroxon
MaaT Pharma to seek review after CHMP negative opinion on MaaT013 application
Sensei Biotherapeutics changes name to Faeth Therapeutics
Datavault AI and Wellgistics Health plan DelivMeds AI healthcare venture
Intensity Therapeutics receives Cancer Treatment Technology Innovator of the Year award
Solvonis Therapeutics appoints Water Tower Research to strengthen US market positioning
Atrium Therapeutics announces inducement grants to seven new employees
GXO appointed to manage NHS England bowel cancer home testing kits